Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Dermatologic 1

Conditions

Hodgkin Disease 6Sarcoma 3Melanoma 2Leiomyosarcoma 2Sarcoma, Synovial 1Sarcoma, Alveolar Soft Part 1Melanoma, Cutaneous Malignant 1Lymphoma 1Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8 1Hyperthermia 1Advanced Melanoma 1

Interventions

Temozolomide 1Paclitaxel 1Dacarbazine 1Cisplatin 1Carboplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Advanced Melanoma × Dacarbazine × Clear all
NCT07310784 2026-05-12

A Phase II Trial of LM103 in Advanced Melanoma

Suzhou BlueHorse Therapeutics Co., Ltd.

Phase 2 Recruiting
92 enrolled
Dermatologic

Advanced Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡